SCHEMBL19928752

SCHEMBL19928752

CC(=O)C(F)(F)c1ccc(CNC(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.46
RAB9A P51151 1/20 0.46
MAPK14 Q16539 1/20 0.46
EPHX2 P34913 5/20 0.45
NR1H4 Q96RI1 3/20 0.45
KMT2A Q03164 1/20 0.45
KIF11 P52732 1/20 0.45
LSS P48449 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
GRB2 P62993 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695141 0.82 MTOR (0.58) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL4618832 0.79 EPHX2 (0.68) CYP1A2CYP2C19LMNARAB9AEPHX2
SCHEMBL19925323 0.79 EPHX2 (0.48) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL26119530 0.79 EPHX2 (0.48) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL26119278 0.78 MLYCD (0.52) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL19925289 0.78 EPHX2 (0.44) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL11533429 0.78 CYP2C9 (0.65) CYP1A2CYP2D6CYP2C9TSHRCYP2C19
SCHEMBL18585658 0.77 AKR1B1 (0.52) TSHRLMNAEPHX2NR1H4ALDH1A1
SCHEMBL26382764 0.75 POLB (0.44) CYP1A2CYP2D6CYP2C9CYP2C19KMT2A
SCHEMBL3577345 0.75 LMNA (0.60) CYP1A2CYP2C19LMNARAB9AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018042342-A1 1,2,3-BENZOTRIAZOLE DERIVATIVES AS ROR GAMMA T MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2018-03-08 WO disclosed